These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10768157)

  • 41. Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.
    Dean C; Mosier M; Penry K
    Epilepsia; 1999 Jan; 40(1):74-82. PubMed ID: 9924905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.
    French JA; Mosier M; Walker S; Sommerville K; Sussman N
    Neurology; 1996 Jan; 46(1):54-61. PubMed ID: 8559421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Open label trial with vigabatrin in children with intractable epilepsy.
    Wong V
    Brain Dev; 1995; 17(4):249-52. PubMed ID: 7503385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
    Dalla Bernardina B; Fontana E; Vigevano F; Fusco L; Torelli D; Galeone D; Buti D; Cianchetti C; Gnanasakthy A; Iudice A
    Epilepsia; 1995 Jul; 36(7):687-91. PubMed ID: 7555986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population dose-response analysis of daily seizure count following vigabatrin therapy in adult and pediatric patients with refractory complex partial seizures.
    Nielsen JC; Hutmacher MM; Wesche DL; Tolbert D; Patel M; Kowalski KG
    J Clin Pharmacol; 2015 Jan; 55(1):81-92. PubMed ID: 25117853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy.
    Jackson MC; Jafarpour S; Klehm J; Thome-Souza S; Coughlin F; Kapur K; Loddenkemper T
    Epilepsia; 2017 Sep; 58(9):1575-1585. PubMed ID: 28691157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vigabatrin pediatric dosing information for refractory complex partial seizures: results from a population dose-response analysis.
    Nielsen JC; Tolbert D; Patel M; Kowalski KG; Wesche DL
    Epilepsia; 2014 Dec; 55(12):e134-8. PubMed ID: 25311090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
    Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
    Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
    Mattson RH; Petroff O; Rothman D; Behar K
    Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vigabatrin administration for infants and young children with intractable generalized epilepsy].
    Kita S; Nishimura Y; Togawa M; Maegaki Y
    No To Hattatsu; 2016 Jul; 48(4):265-70. PubMed ID: 30010934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C; Beaumont D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study.
    Tanganelli P; Regesta G
    Epilepsy Res; 1996 Nov; 25(3):257-62. PubMed ID: 8956924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of lamotrigine in medically intractable epilepsies in children.
    Zubcevic S; Cengic A; Catibusic F; Uzicanin S
    Med Arh; 2008; 62(3):162-4. PubMed ID: 18822946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; Napoliello MJ; Sherry KM; Szabo GK
    Neurology; 1987 Feb; 37(2):184-9. PubMed ID: 3808298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vigabatrin treatment in children.
    Fois A; Buoni S; Di Bartolo RM; Di Marco V; Mostardini R
    Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.